Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Silgan Holdings Inc. continues to demonstrate operational resilience and strong cash flow generation despite mixed consumer sentiment and raw material cost volatility. The company's strategic focus on high-value dispensing and specialty closures, combined with its defensive metal food container business, provides a robust margin profile. With a confirmed free cash flow target of approximately $450 million for 2026 and a disciplined capital allocation strategy, Silgan is well-positioned to reduce its leverage rapidly while supporting its long-term dividend growth track record.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets13 analysts · as of 18 Aug 2026
Low · most bearish analyst$47.00
Mean target$55.31
High · most bullish analyst$61.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$47.00

Persistent raw material cost inflation, particularly in resin and steel, combined with prolonged customer destocking and weaker consumer demand for packaged goods, compresses margins. Restructuring charges and higher interest expenses drag adjusted EPS below the guided range, slowing down the deleveraging process.

Base CaseCentral scenario
$55.31
Matches the consensus mean

Silgan delivers on its updated full-year 2026 adjusted EPS guidance of $3.73 to $3.93 and achieves its free cash flow target of approximately $450 million. Modest volume growth across segments and disciplined cost management offset near-term resin inflation and weather-related disruptions, maintaining stable margins.

Bull CaseUpside scenario
$61.00

Accelerated volume recovery in high-margin dispensing products for fragrance, beauty, and pet food markets, coupled with rapid integration and synergy realization from the Weener Plastics acquisition, drives earnings toward the high end of guidance. Stronger-than-expected cash generation enables aggressive debt paydown and early activation of the $500 million share buyback program.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Strong and highly visible free cash flow generation, with a confirmed 2026 target of approximately $450 million.
  • Resilient business model supported by long-term customer partnerships and contractual pass-through of raw material costs.
  • Proven track record of dividend growth, with 22 consecutive years of dividend increases.
  • Growth catalysts in high-value dispensing and specialty closures, particularly in fragrance, beauty, and healthcare markets.
Sign in / Sign up to read more
Key Investment Risks
  • Exposure to raw material price volatility (resin, steel, aluminum) and potential lags in contractual pass-through mechanisms.
  • Customer destocking trends and shifts in consumer spending patterns on packaged goods.
  • Relatively high leverage following strategic acquisitions, with net debt standing at approximately 3.5x EBITDA at the end of 2025.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. Failure to achieve the guided 2026 free cash flow of $450 million due to severe margin compression or working capital drag.
  2. A significant drop in dispensing segment volumes indicating structural market share loss or permanent demand destruction.
  3. Inability to pass through escalating raw material costs, leading to a multi-quarter decline in Adjusted EBIT.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.